{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:47:26Z","timestamp":1762865246664,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1124\/dmd.106.012245","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T05:48:59Z","timestamp":1169704139000},"page":"640-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development of Three Parallel Cytochrome P450 Enzyme Affinity Detection Systems Coupled On-line to Gradient High-Performance Liquid Chromatography"],"prefix":"10.1016","volume":"35","author":[{"given":"Jeroen","family":"Kool","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan M.","family":"van Liempd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huub","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny A.","family":"van Elswijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubertus","family":"Irth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan N.M.","family":"Commandeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico P.E.","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.106.012245_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jps.10545","article-title":"High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism","volume":"93","author":"Ansede","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.106.012245_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/rcm.290","article-title":"High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1","volume":"15","author":"Bu","year":"2001","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.106.012245_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0378-4347(00)00570-3","article-title":"High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. II. Validation of a direct injection\/online guard cartridge extraction-tandem mass spectrometry method for CYP2D6 inhibition assessment","volume":"753","author":"Bu","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1124\/dmd.106.012245_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(94)90363-8","article-title":"Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver","volume":"48","author":"Burke","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.106.012245_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jbt.2570100604","article-title":"Differential regulation of cytochrome P450 3A1 and P450 3A2 in rat liver following dexamethasone treatment","volume":"10","author":"Choudhuri","year":"1995","journal-title":"J Biochem Toxicol"},{"key":"10.1124\/dmd.106.012245_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1056-8719(00)00112-X","article-title":"Fluorometric screening for metabolism-based drug\u2013drug interactions","volume":"44","author":"Crespi","year":"2000","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/dmd.106.012245_bib7","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1021\/jm040066v","article-title":"Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery","volume":"47","author":"Fura","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.106.012245_bib8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0731-7085(94)00100-6","article-title":"Photostability determination of commercially available nifedipine oral dosage formulations","volume":"12","author":"Grundy","year":"1994","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.106.012245_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/tx0002583","article-title":"Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity","volume":"14","author":"Guengerich","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.106.012245_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/00498258209038945","article-title":"Purification and characterization of microsomal cytochrome P-450s","volume":"12","author":"Guengerich","year":"1982","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.106.012245_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01715634","article-title":"Multidimensional chromatography coupled with mass spectrometry for target-based screening","volume":"2","author":"Hsieh","year":"1997","journal-title":"Mol Divers"},{"key":"10.1124\/dmd.106.012245_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/1386207023330101","article-title":"Improvement of \u201chit-to-lead\u201d optimization by integration of in vitro HTS experimental models for early determination of pharmacokinetic properties","volume":"5","author":"Kariv","year":"2002","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1124\/dmd.106.012245_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0006-2952(01)00843-7","article-title":"Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat","volume":"63","author":"Kobayashi","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.106.012245_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1087057105274904","article-title":"Development of a novel cytochrome p450 bioaffinity detection system coupled online to gradient reversed-phase high-performance liquid chromatography","volume":"10","author":"Kool","year":"2005","journal-title":"J Biomol Screen"},{"key":"10.1124\/dmd.106.012245_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1386207013331101","article-title":"In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery","volume":"4","author":"Masimirembwa","year":"2001","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1124\/dmd.106.012245_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2125.2000.00193.x","article-title":"Nonspecific binding of drugs to human liver microsomes","volume":"49","author":"McLure","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.106.012245_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-4347(93)E0405-F","article-title":"Bioanalysis of digoxin and its metabolites using direct serum injection combined with liquid chromatography and on-line immunochemical detection","volume":"653","author":"Oosterkamp","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1124\/dmd.106.012245_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/tx0001326","article-title":"Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates","volume":"14","author":"Rooseboom","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.106.012245_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0163-7258(90)90029-2","article-title":"Purification and characterization of hepatic microsomal cytochrome P-450","volume":"45","author":"Ryan","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.106.012245_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1087057103255973","article-title":"Screening of natural products extracts for the presence of phosphodiesterase inhibitors using liquid chromatography coupled online to parallel biochemical detection and chemical characterization","volume":"8","author":"Schenk","year":"2003","journal-title":"J Biomol Screen"},{"key":"10.1124\/dmd.106.012245_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/108705710100600503","article-title":"High resolution screening of plant natural product extracts for estrogen receptor alpha and beta binding activity using an online HPLC-MS biochemical detection system","volume":"6","author":"Schobel","year":"2001","journal-title":"J Biomol Screen"},{"key":"10.1124\/dmd.106.012245_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdd.278","article-title":"Analysis and screening of combinatorial libraries using mass spectrometry","volume":"22","author":"Shin","year":"2001","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.106.012245_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/dmd.30.7.845","article-title":"Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4","volume":"30","author":"Stresser","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.012245_bib24","first-page":"85","article-title":"Metabolic screening using on-line ultrafiltration mass spectrometry","volume":"26","author":"van Breemen","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.012245_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.chroma.2003.08.055","article-title":"Rapid detection and identification of angiotensin-converting enzyme inhibitors by on-line liquid chromatography-biochemical detection, coupled to electrospray mass spectrometry","volume":"1020","author":"van Elswijk","year":"2003","journal-title":"J Chromatogr A"},{"key":"10.1124\/dmd.106.012245_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.chroma.2005.03.084","article-title":"Development and validation of a microsomal online cytochrome P450 bioreactor coupled to solid-phase extraction and reversed-phase liquid chromatography","volume":"1075","author":"van Liempd","year":"2005","journal-title":"J Chromatogr A"},{"key":"10.1124\/dmd.106.012245_bib27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/1568026033451998","article-title":"Prediction of drug metabolism: the case of cytochrome P450 2D6","volume":"3","author":"Vermeulen","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/dmd.106.012245_bib28","first-page":"185","article-title":"Methanol solvent may cause increased apparent metabolic instability in in vitro assays","volume":"29","author":"Yin","year":"2001","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624012728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624012728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.106.012245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:21:54Z","timestamp":1739895714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624012728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0090955624012728"],"URL":"https:\/\/doi.org\/10.1124\/dmd.106.012245","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Three Parallel Cytochrome P450 Enzyme Affinity Detection Systems Coupled On-line to Gradient High-Performance Liquid Chromatography","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.106.012245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}